Currently, the following topics are under consideration for inclusion in future Innovative Medicines Initiative (IMI) Calls:
- Translational approaches to disease modifying therapy of Type 1 Diabetes Mellitus (T1DM)
- Discovery and validation of novel endpoints in retinal diseases
- RADAR: Remote assessment of disease and relapse